57 research outputs found
Associations Between Body Mass Index, Ambulatory Blood Pressure Findings, and Changes in Cardiac Structure: Relevance of Pulse and Nighttime Pressures
Ambulatory blood pressure monitoring (ABPM) is central in the management of hypertension. Factors related to BP, such as body mass index (BMI), may differently affect particular aspects of 24-hour ABPM profiles. However, the relevance of BMI, the most used index of adiposity, has been underappreciated in the determination of specific aspects of 24-hour ABPM profiles in hypertension. The authors evaluated the association between BMI and aspects of ABPM together with their associations with cardiac remodeling in 1841 patients. A positive association of BMI with 24-hour, daytime, and nighttime pulse pressure in untreated normal weight and overweight/obese hypertensive patients and a positive association of BMI with nocturnal BP parameters in treated overweight/obese hypertensive patients was observed. The clinical relevance of these findings was supported by the positive significant correlations of BMI-related BPs with left ventricular mass and atrial diameter
Hypertensive heart disease and obesity: a complex interaction between hemodynamic and non hemodynamic factors.
The worldwide prevalence of obesity has nearly doubled, with an increase in obesity-related cardiovascular disease and mortality. Several factors are involved in the genesis of hypertension and hypertensive heart disease (HHD) in overweight/obesity. This review is focused on bridging factors between excessive adiposity and HHD, presenting a unifying hypothesis of vascular-metabolic syndrome, where an "handicap" of the natriuretic peptide system has a central role both in adipocyte dysmetabolism as well as in increased blood pressure and HHD
Effects of levodopa alone and in combination with DOPA-decarboxylase inhibitors on plasma renin activity in patients with Parkinson's disease
Abstract
Plasma renin activity (PRA) of patients with Parkinson's disease was measured in recumbency, upright position, and after frusemide administration. The results show that the renin responses to both stimuli are significantly reduced as compared with those obtained in a group of normal subjects, while recumbent PRA levels of Parkinsonism patients are not significantly lower than those found in recumbent normal subjects. Levodopa treatment, alone or in combination with two different dopa-decarboxylase inhibitors, benserazide and carbidopa, does not modify the renin response to posture or to frusemide. Although the reduced activity of the renin-angiotensin system can play some role in the genesis of orthostatic hypotensive episodes encountered in patients with Parkinsonism, the greater incidence of orthostatis hypotension in patients treated with levodopa seems to be unrelated to any effect of this drug on the renin release
Plasma aldosterone is increased in class 2 and 3 obese essential hypertensive patients despite drug treatment.
Abstract:
Background
The aim of this study was to evaluate whether body mass index (BMI)
is independently correlated with plasma aldosterone concentration
(PAC) in treated essential hypertensive patients, and whether the
relationship between BMI and high blood pressure (BP) can be
partially mediated by PAC despite renin–angiotensin–aldosterone
system blockade.
Methods
This study used a cross-sectional design and included 295
consecutive essential hypertensive patients referred to our centre
for uncontrolled BP despite stable antihypertensive treatment
for at least 6 months. The main exclusion criteria were age >65
years; glomerular filtration rate <30 ml/min; and therapy with
mineralocorticoid receptor antagonists, direct renin inhibitors,
amiloride or oral contraceptives.
Results
Higher levels of obesity showed a significantly higher mean PAC with
a steep nonlinear increase in patients with BMI ≥35 kg/m2. Class 2 and
3 obese patients had a higher mean PAC than nonobese and class 1
obese patients, even in patients under stable treatment with either
angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin
receptor blockers (ARBs). In a stepwise multiple linear regression
model, only log of plasma renin activity (PRA), mean blood pressure
(MBP), and class 2 and 3 obesity showed an independent correlation
with PAC. In the same model applied to patients treated with ACEIs
or ARBs, only logPRA and class 2 and 3 obesity showed a direct
correlation with PAC.
Conclusions
In treated essential hypertensive patients, a BMI ≥35 kg/m2 is
independently, albeit modestly, correlated with PAC. The correlation
between BMI ≥35 kg/m2 and PAC holds true even in ACEI/ARBtreated
patients. Further study is required to determine whether the
association of obesity with BP is mediated by PAC in hypertensive
patients on stable therapy with ACEIs or ARBs
- …